Anti-PA2GE/ PLA2G2E/ GIIE sPLA2 functional antibody

Anti-PA2GE/ PLA2G2E/ GIIE sPLA2 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to PLA2G2E/PLA2G2E products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0412-Ab-1/ GM-Tg-hg-SE0412-Ab-2Anti-Human PLA2G2E monoclonal antibodyHuman
GM-Tg-rg-SE0412-Ab-1/ GM-Tg-rg-SE0412-Ab-2Anti-Rat PLA2G2E monoclonal antibodyRat
GM-Tg-mg-SE0412-Ab-1/ GM-Tg-mg-SE0412-Ab-2Anti-Mouse PLA2G2E monoclonal antibodyMouse
GM-Tg-cynog-SE0412-Ab-1/ GM-Tg-cynog-SE0412-Ab-2Anti-Cynomolgus/ Rhesus macaque PLA2G2E monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0412-Ab-1/ GM-Tg-felg-SE0412-Ab-2Anti-Feline PLA2G2E monoclonal antibodyFeline
GM-Tg-cang-SE0412-Ab-1/ GM-Tg-cang-SE0412-Ab-2Anti-Canine PLA2G2E monoclonal antibodyCanine
GM-Tg-bovg-SE0412-Ab-1/ GM-Tg-bovg-SE0412-Ab-2Anti-Bovine PLA2G2E monoclonal antibodyBovine
GM-Tg-equg-SE0412-Ab-1/ GM-Tg-equg-SE0412-Ab-2Anti-Equine PLA2G2E monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0412-Ab-1/ GM-Tg-hg-SE0412-Ab-2; GM-Tg-rg-SE0412-Ab-1/ GM-Tg-rg-SE0412-Ab-2;
GM-Tg-mg-SE0412-Ab-1/ GM-Tg-mg-SE0412-Ab-2; GM-Tg-cynog-SE0412-Ab-1/ GM-Tg-cynog-SE0412-Ab-2;
GM-Tg-felg-SE0412-Ab-1/ GM-Tg-felg-SE0412-Ab-2; GM-Tg-cang-SE0412-Ab-1/ GM-Tg-cang-SE0412-Ab-2;
GM-Tg-bovg-SE0412-Ab-1/ GM-Tg-bovg-SE0412-Ab-2; GM-Tg-equg-SE0412-Ab-1/ GM-Tg-equg-SE0412-Ab-2
Products NameAnti-PLA2G2E monoclonal antibody
Formatmab
Target NamePLA2G2E
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-PLA2G2E benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0412-Ag-1Recombinant multi-species PA2GE/ PLA2G2E/ GIIE sPLA2 protein


    Target information

    Target IDGM-SE0412
    Target NamePLA2G2E
    Gene ID30814,26970,298581,704299,506243,100071870
    Gene Symbol and SynonymsGIIE sPLA2,PLA2G2E,sPLA2-IIE
    Uniprot AccessionQ9NZK7
    Uniprot Entry NamePA2GE_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000188784
    Target ClassificationN/A

    The target: PLA2G2E, gene name: PLA2G2E, also named as GIIE sPLA2, sPLA2-IIE. Enables calcium ion binding activity and calcium-dependent phospholipase A2 activity. Predicted to be involved in phospholipid metabolic process. Predicted to act upstream of or within low-density lipoprotein particle remodeling. Predicted to be located in extracellular region. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.